Alpha Cognition Inc. Depreciation
Alpha Cognition Inc. (ACOG) reported Depreciation of $1.90 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-05-15
- Alpha Cognition Inc. depreciation for the quarter ending 2025-03-31 was $1.90K, a 699.58% increase year-over-year.
- Alpha Cognition Inc. depreciation for the quarter ending 2024-12-31 was $635.00, a 20.72% increase year-over-year.
- Alpha Cognition Inc. depreciation for the quarter ending 2024-09-30 was $236.00, a 55.05% decline year-over-year.
- Alpha Cognition Inc. depreciation for the quarter ending 2024-06-30 was $237.00, a 54.94% decline year-over-year.
- Alpha Cognition Inc. depreciation for fiscal 2024 was $1.34K, a 36.04% decline from fiscal 2023.
- Alpha Cognition Inc. depreciation for fiscal 2023 was $2.10K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-03-31 | $1.90K 10-Q · filed 2025-05-15 | $2.53K derived: sum of 2 quarters · filed 2025-05-15 | $2.77K derived: sum of 3 quarters · filed 2025-05-15 | $3.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $635.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $871.00 derived: sum of 2 quarters · filed 2025-03-31 | $1.11K derived: sum of 3 quarters · filed 2025-03-31 | $1.34K 10-K · filed 2025-03-31 |
| 2024-09-30 | $236.00 10-Q · filed 2024-11-14 | $473.00 derived: sum of 2 quarters · filed 2024-11-14 | $710.00 10-Q · filed 2024-11-14 | $1.24K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $237.00 10-Q · filed 2024-08-12 | $474.00 10-Q · filed 2024-08-12 | $1.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.52K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $237.00 10-Q · filed 2025-05-15 | $763.00 derived: sum of 2 quarters · filed 2025-05-15 | $1.29K derived: sum of 3 quarters · filed 2025-05-15 | $1.81K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $526.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.05K derived: sum of 2 quarters · filed 2025-03-31 | $1.58K derived: sum of 3 quarters · filed 2025-03-31 | $2.10K 10-K · filed 2025-03-31 |
| 2023-09-30 | $525.00 10-Q · filed 2024-11-14 | $1.05K derived: sum of 2 quarters · filed 2024-11-14 | $1.58K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $526.00 10-Q · filed 2024-08-12 | $1.05K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |